Skip to content

Effect of Vitamin D Supplement on Prevention of Preeclampsia in Pregnant Women

Comparing the Impact of Vitamin D Supplementation with Placebo on Pre-eclampsia Prevention in Pregnant Women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230814059146N1
Enrollment
250
Registered
2023-08-22
Start date
2022-01-19
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-eclampsia: The occurrence of hypertension in pregnancy after 20 weeks of gestation. Pre-eclampsia

Interventions

Intervention 1: Intervention group: In intervention group patients were given 50000 IU capsules of vitamin D3 once every 2 weeks. All patients were advised to take medicine (placebo or vitamin D) til

Sponsors

DME of Nishtar hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Presented with prenatal care in outpatient department previous history of Preeclampsia gestational age of >20 weeks

Exclusion criteria

Exclusion criteria: History of renal insufficiency History of cardiac disease History of hypertension before pregnancy lack of confidence in cooperation history of immunological disease patient willing to leave during trial

Design outcomes

Primary

MeasureTime frame
Pre-eclampsia (Blood pressure measurement and proteinuria). Timepoint: From 20 weeks till 36 weeks of gestation, (every two weeks). Method of measurement: Blood pressure measurement using sphygmomanometer, and proteinuria by dipstick method.

Secondary

MeasureTime frame
Type of delivery. Timepoint: At 40 weeks approximately. Method of measurement: Visual and medical record.;Abortion rate. Timepoint: From 20 weeks till abortion. Method of measurement: Based on history and medical records.

Countries

Pakistan

Contacts

Public ContactDr. Saima

DME, Nishtar hospital Multan

saimashahzad35177@gmail.com+92 311 8443876

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026